Genelux

• Home
• About
  1. Board of Directors
  2. Management Team
  3. Advisory Boards
• Technology
  1. Science Division
  2. Therapy
  3. Imaging
• Products
  1. GL-ONC1
  2. Future Products
• Clinical Trials
  1. Clinical Trials Operations
  2. About Clinical Trials
• Patents & Publications
  1. Scientific Publications
  2. Intellectual Property
• News & Events
  1. Press Releases
  2. In The News
  3. Events & Conferences
  4. Media Relations Contact
• Investor Relations
• Careers
• Contact

Future Products

Scientists at Genelux continue to explore innovative ways to enhance and adapt the Genelux technology. Opportunities to further optimize the virus for specific types of cancers, patients or imaging modalities are immense.

The large insertion carrying capacity of the virus could enable the development of combination therapies that would use viruses to deliver traditional cytotoxic anti-cancer drugs specifically to tumors.